2021 Part D Outlook on Insulin / 2021 MA Outlook on ERSD
2021 Part D Outlook – New Model Part D Plan Will Offer $35 Insulin
On March 11, 2020 CMS announced a Part D Senior Savings Model that allows Medicare Part D prescription drug plans to offer beneficiaries plan choices that provide a broad range of insulins at no more than a $35 copay. CMS will provide information on which plans are participating in the Model as part of Medicare Open Enrollment.
Source: https://www.cms.gov/newsroom/fact-sheets/part-d-senior-savings-model
2021 MA Outlook – ESRD Will No Longer Exclude an Individual from Medicare Advantage Enrollment
Insurers are preparing financially for new eligibility for Medicare beneficiaries with ESRD to choose a Medicare Advantage Plan. Currently, a Medicare beneficiary with ESRD can only sign up for Medicare Advantage Plan if they were already in a Medicare Advantage Plan when they got diagnosed with kidney disease. But starting in 2021, due to a provision of the 21st Century Cures Act, a Medicare beneficiary with ESRD can enroll in a Medicare Advantage Plan even if they were not in one before.